Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medpace Holdings, Inc.MEDP · Entity 3327 | Director | August 19, 2026 | August 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medpace Holdings, Inc.
Report date August 19, 2026 · Filed August 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,798 |
Ending reported balance
After 2026-08-19 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-08-19 · Exercise / conversion · Acquired 1,903 · Balance 5,401 Row 2 · 2026-08-19 · Exercise / conversion · Acquired 3,858 · Balance 9,259 Row 3 · 2026-08-19 · Exercise / conversion · Acquired 1,822 · Balance 11,081 Row 4 · 2026-08-19 · Sale · Disposed 7,283 · Balance 3,798 F1: The reported price is a weighted average price. The shares were sold in multiple transactions ranging from $605.59 to $607.202. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $133.87 · Expires 2029-05-20 | Direct | 0 |
Reported balance
After 2026-08-19 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-08-19 · Exercise / conversion · Disposed 1,903 · Balance 0 F3: The option vested in full on 05/18/2023. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $84.36 · Expires 2027-05-15 | Direct | 0 |
Reported balance
After 2026-08-19 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-08-19 · Exercise / conversion · Disposed 3,858 · Balance 0 F4: The option vested in full on 05/13/2021. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $164.68 · Expires 2028-05-14 | Direct | 0 |
Reported balance
After 2026-08-19 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-08-19 · Exercise / conversion · Disposed 1,822 · Balance 0 F5: The option vested in full on 05/14/2022. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 2,000 |
Reported balance
Holding disclosure · report date 2026-08-19 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 2,000 F2: Owned by trust for the benefit of the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported price is a weighted average price. The shares were sold in multiple transactions ranging from $605.59 to $607.202. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F2: Owned by trust for the benefit of the Reporting Person.
F3: The option vested in full on 05/18/2023.
F4: The option vested in full on 05/13/2021.
F5: The option vested in full on 05/14/2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 19, 2026 Filed Aug 21, 2026 20:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,822 | $0.00 Strike: $164.68 | $0.00 |
DisclosureSEC source: 0000892251-26-000123 · form4.xml · derivative · entry 8 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,822 shares Expires 2028-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vested in full on 05/14/2022. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,858 | $0.00 Strike: $84.36 | $0.00 |
DisclosureSEC source: 0000892251-26-000123 · form4.xml · derivative · entry 7 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,858 shares Expires 2027-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in full on 05/13/2021. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,903 | $0.00 Strike: $133.87 | $0.00 |
DisclosureSEC source: 0000892251-26-000123 · form4.xml · derivative · entry 6 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,903 shares Expires 2029-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in full on 05/18/2023. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 7,283 | $606.15 | $4,414,590.45 |
DisclosureSEC source: 0000892251-26-000123 · form4.xml · nonDerivative · entry 4 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,798 F1 · price: The reported price is a weighted average price. The shares were sold in multiple transactions ranging from $605.59 to $607.202. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 1,822 | $164.68 | $300,046.96 |
DisclosureSEC source: 0000892251-26-000123 · form4.xml · nonDerivative · entry 3 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 3,858 | $84.36 | $325,460.88 |
DisclosureSEC source: 0000892251-26-000123 · form4.xml · nonDerivative · entry 2 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 1,903 | $133.87 | $254,754.61 |
DisclosureSEC source: 0000892251-26-000123 · form4.xml · nonDerivative · entry 1 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2026 Filed May 18, 2026 21:04 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 1,110 | $0.00 Strike: $415.27 | $0.00 |
DisclosureSEC source: 0001181154-26-000002 · wk-form4_1779138265.xml · derivative · entry 3 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,110 Underlying: Common Stock · 1,110 shares Expires 2033-05-15 F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 21:46 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,472 | $0.00 Strike: $54.99 | $0.00 |
DisclosureSEC source: 0001181154-25-000004 · wk-form4_1762206393.xml · derivative · entry 4 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,472 shares Expires 2026-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in full on May 14, 2020. Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 21:46 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 5,972 | $581.88 | $3,474,987.36 |
DisclosureSEC source: 0001181154-25-000004 · wk-form4_1762206393.xml · nonDerivative · entry 2 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,498 F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $580.53 to $585.26. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 21:46 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 6,472 | $54.99 | $355,895.28 |
DisclosureSEC source: 0001181154-25-000004 · wk-form4_1762206393.xml · nonDerivative · entry 1 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:33 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 1,224 | $0.00 Strike: $305.66 | $0.00 |
DisclosureSEC source: 0001668397-25-000065 · wk-form4_1747773172.xml · derivative · entry 3 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,224 Underlying: Common Stock · 1,224 shares Expires 2032-05-16 F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| April 24, 2025 Filed Apr 28, 2025 20:39 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,710 | $0.00 Strike: $57.17 | $0.00 |
DisclosureSEC source: 0001668397-25-000061 · wk-form4_1745872747.xml · derivative · entry 4 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,710 shares Expires 2025-08-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in full on May 16, 2019. Read SEC document |
| April 24, 2025 Filed Apr 28, 2025 20:39 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 1,712 | $301.82 | $516,715.84 |
DisclosureSEC source: 0001668397-25-000061 · wk-form4_1745872747.xml · nonDerivative · entry 2 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,998 Read SEC document |
| April 24, 2025 Filed Apr 28, 2025 20:39 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 4,710 | $57.17 | $269,270.70 |
DisclosureSEC source: 0001668397-25-000061 · wk-form4_1745872747.xml · nonDerivative · entry 1 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2024 Filed May 21, 2024 20:32 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 953 | $0.00 Strike: $393.30 | $0.00 |
DisclosureSEC source: 0001668397-24-000105 · wk-form4_1716323543.xml · derivative · entry 2 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 953 Underlying: Common Stock · 953 shares Expires 2031-05-17 F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| May 19, 2023 Filed May 23, 2023 20:24 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 1,769 | $0.00 Strike: $210.88 | $0.00 |
DisclosureSEC source: 0000892251-23-000059 · form4.xml · derivative · entry 2 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,769 Underlying: Common Stock · 1,769 shares Expires 2030-05-19 F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| May 20, 2022 Filed May 24, 2022 20:16 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 1,903 | $0.00 Strike: $133.87 | $0.00 |
DisclosureSEC source: 0001567619-22-011617 · doc1.xml · derivative · entry 2 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,903 Underlying: Common Stock · 1,903 shares Expires 2029-05-20 F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 21:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | PurchaseCommon Stock | 500 | $145.80 | $72,900.00 |
DisclosureSEC source: 0001567619-22-005254 · doc1.xml · nonDerivative · entry 1 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 2,000 F1 · ownership.nature: Owned by trust for the benefit of the Reporting Person. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:29 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 1,822 | $0.00 Strike: $164.68 | $0.00 |
DisclosureSEC source: 0001567619-21-010623 · doc1.xml · derivative · entry 2 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,822 Underlying: Common Stock · 1,822 shares Expires 2028-05-14 F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:13 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 3,858 | $0.00 Strike: $84.36 | $0.00 |
DisclosureSEC source: 0001567619-20-010757 · doc1.xml · derivative · entry 2 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,858 Underlying: Common Stock · 3,858 shares Expires 2027-05-15 F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:54 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 6,472 | $0.00 Strike: $54.99 | $0.00 |
DisclosureSEC source: 0001567619-19-011792 · doc1.xml · derivative · entry 2 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,472 Underlying: Common Stock · 6,472 shares Expires 2026-05-17 F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 20:50 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantStock Option (Right to Buy) · Derivative | 4,710 | $0.00 Strike: $57.17 | $0.00 |
DisclosureSEC source: 0001567619-18-001191 · doc1.xml · derivative · entry 2 DAVENPORT FRED B JR · CIK 0001181154 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,710 Underlying: Common Stock · 4,710 shares Expires 2025-08-13 F2 · derivative.exercise_date: The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.